Development of Pathways for Oncological Patients (73220000-0, 73200000-4)

KazakhTenders notice for Development of Pathways for Oncological Patients (73220000-0, 73200000-4). The reference ID of the tender is 107459950 and it is closing on 04 Oct 2024.

100% Secure Payments

Tender Details

  • Country: Latvia
  • Summary: Development of Pathways for Oncological Patients (73220000-0, 73200000-4)
  • KZT Ref No: 107459950
  • Deadline: 04 Oct 2024
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 28000
  • Notice Type: Tender
  • Document Ref. No.: RAKUS 2024/115M
  • Purchaser's Detail :
  • Purchaser : SIA "RĪGAS ASTRUMU KLINISKKA UNIVERSITY HOSPITAL" (40003951628)
    SIA "Rīga Eastern Clinical University Hospital", iepirkumi@aslimnica.lv, +37167042336
    Email :iepirkumi@aslimnica.lv
    URL :https://www.eis.gov.lv/EKEIS/Supplier/Organizer/309

  • Description :
  • Proposals are invited for Oncology Patient Pathway Development (73220000-0, 73200000-4)
    Procurement description: Oncology Patient Pathway Development
    Submission deadline: 04/10/2024
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
KazakhTenders Features

KazakhTenders Features

Fresh and verified Tenders from Kazakh. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Kazakh in your email inbox.

  Chat with us